Authors


R. Christopher Barden, PhD, JD

Latest:

Reforming Mental Health Care: How Ending “Recovered Memory” Treatments Brought Informed Consent to Psychotherapy

How the Repressed-Recovered Memory–Multiple Personality Disorder iatrogenic epidemic-surely one of the most tragic chapters in the history of psychiatry, psychology, and psychotherapy-ended, and how psychotherapy patients came to be protected by informed consent.


R. Gregg Dwyer, MD, EdD

Latest:

Conference Preview from the Cutting Edge

A look at the 2015 joint American Society for Adolescent Psychiatry (ASAP) and International Society for Adolescent Psychiatry and Psychology (ISAPP) Scientific Meeting in March. There, the author will be presenting two sessions that address adolescent sexuality and sexual development issues.


Rachel A. Rabin, MSc

Latest:

Schizophrenia, Neurocognitive Dysfunction, and Substance-Related Disorders: A Review

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.


Rachel Emily Maurer, MD

Latest:

Obstructive Sleep Apnea and Depression: Issues for Psychiatrists

What are the effects of sleep apnea on depression--and depression on sleep apnea? Insights here.


Rachel Lipson Glick, MD

Latest:

Improving Care Through Cultural Awareness

All clinicians know that culture influences virtually every aspect of a person's life. Sometimes the influence of culture is obvious; other times it is subtle. In either case, culture as a clinical variable is often overlooked. Being cognizant of the influence of culture is especially important for clinicians who manage psychiatric emergencies, because failing to do so can lead to misdiagnosis and delays in treatment.


Rachel Lynn, MD

Latest:

Breast Cancer: What Psychiatrists Need to Know

To support patients with breast cancer, psychiatrists should be aware of possible medication interactions, psychiatric or neurologic adverse effects of treatment, and signs of disease progression--issues that are the focus here.


Rachel Shmuts, DO

Latest:

From Unwanted to Unconditional: How One Mother's Love Changed My Career

Up until her last year of training, this psychiatrist was convinced she only wanted to consult in the hospital-that is, until she met a 31-year-old expectant mother.


Rachel Yehuda, PhD

Latest:

Is PTSD a Systemic Disorder?

In addition to psychosocial problems, there is a growing realization that PTSD may also lead to or exacerbate chronic medical health conditions.


Radwane Kesserwane, MD

Latest:

Anxiety Disorders: Aortic Aneurysm in the Differential?

Worsening anxiety is a common symptom that may result in psychiatric consultation or evaluation in an emergency setting. Aneurysms are rarely considered in the medical differential for anxiety disorders, and the available literature and research regarding this possible connection are very limited. Overlooking this diagnosis, however, can have disastrous consequences. Here we present 2 case reports as well as a review of the literature regarding a possible relationship between aortic and thoracic aneurysms and psychiatric symptoms.


Rafael A Calvo, PhD

Latest:

Positive Computing and Designing for Mental Health

Experts discuss positive computing, an emerging field at the intersection of mental health and technology.


Rahel Eynan, PhD

Latest:

Comorbid Clinical and Personality Disorders: The Risk of Suicide

Personality disorders are arguably the most challenging for psychiatrists because they are difficult to diagnose and frequently coexist with psychotic, affective, and anxiety disorders.


Rahil R. Jummani, MD

Latest:

Are We Overdiagnosing and Overtreating ADHD?

This article speaks to the care with which ADHD must be diagnosed and managed to reduce the significant negative impact of the disorder on the individual, family, and society.


Rahim Shafa, MD

Latest:

Psychiatric Epigenetics: A Key to the Molecular Basis of and Therapy for Psychiatric Disorders

The major challenges for epigenetic therapies are target specificity of the drugs-an issue that is also true for most of the currently used drugs in medicine, especially in psychiatry.


Raj K. Kalapatapu, MD

Latest:

Dementia: A Focused Review

This article reviews the differences between dementia types and future directions.


Rajiv Tandon, MD

Latest:

Psychotic Disorders in DSM-5: Clinical Implications of Revisions From DSM-IV

The authors discuss the clinical implications of the changes in the DSM-5 section on schizophrenia spectrum and other psychotic disorders.


Rajnish Mago, MD

Latest:

Sleep Hygiene: Tips on Getting a Restful Night's Sleep

Concerned about daylight savings time? This patient handout offers tips for getting a good night's sleep.


Rakesh Jain, MD, MPH

Latest:

Why Clinicians Should Be Excited About Austedo XR

Rakesh Jain, MD, shares more about the recent approval of Austedo XR for the treatment of tardive dyskinesia and Huntington disease chorea control.


Rakesh Nanda, MD

Latest:

A Guide to Interventions for Pediatric Seizure Disorders

The Workforce Task Force of the American Academy of Neurology projects that the number of pediatric neurologists will be 20% below demand, at least through the year 2020


Ralph Ankenman, MD

Latest:

Treatment of Sudden, Intense Rage Reactivity After Minor Head Injury

Propranolol therapy at a relatively low dose can cause anger and rage behaviors to subside in some patients. This case describes a man with Down syndrome who, after an accident, sustained minor brain trauma. Subsequently, he regressed to a rage state he had experienced when he was younger.


Ralph E. Tarter, PhD

Latest:

Implications for Treatment and Prognosis of Borderline and Substance Use Disorders

Borderline personality disorder (BPD) and substance use disorder (SUD) often co-occur. Comorbid BPD and SUD is related to a variety of severe adverse outcomes.


Ralph J. Koek, MD

Latest:

Mini Quiz: Treatment for PTSD

Which medications have consistently replicated randomized placebo-controlled trial evidence of efficacy in treating symptoms that are unresponsive to sertraline or paroxetine? Take the quiz and learn more.


Ralph Slovenki

Latest:

Discrediting the Expert Witness on Account of Bias

The issue of psychiatrists serving as forensic expert witnesses has long been controversial. What are the rules for serving as an expert witness, and what is expected of a psychiatrist who serves as an expert witness?


Rama Rao Gogineni, MD

Latest:

SPIRIT (Social Psychiatry Interested in Recovery from International Trauma) Voices Some Current Concerns

All these events that occurred over the weekend bear social psychiatric weight.


Rami Kaminski, MD

Latest:

Cognitive Difficulties Associated With Mental Disorders

Any person who once “drew a blank” during an exam is familiar with the horrors of cognitive difficulties: that terrible moment is for most of us so rare that it remains a traumatic memory for years to come. Imagine those who suffer from protracted cognitive difficulties.


Ramin V. Parsey, MD, PhD

Latest:

Can We Predict Response to Antidepressants?

In this article, we use the example of major depressive disorder (MDD) to review research efforts to identify predictors of treatment response, both to antidepressant medications and to psychotherapy. We describe the promises and limitations of this research, with some emphasis on brain imaging studies, and then discuss how this work may be integrated into clinical practice in the future.


Randal Ross, MD

Latest:

Will Choline Supplementation During Pregnancy Play a Role in Schizophrenia Prevention?

Schizophrenia has long been considered a neurodevelopmental disorder in which onset of diagnostic symptoms in late adolescence or adulthood is the end result of a decades-long interaction between genes and environment that begins in the womb.


Randall D. Marshall, MD

Latest:

Insights Into Depression and Anxiety: Overview of the Anxiety Disorders

Insights Into Depression and Anxiety: Overview of the Anxiety Disorders


Randall Espinoza, MD, MPH

Latest:

Diagnosis and Treatment of Late-Life Depression

Clinicians will likely encounter increasing numbers of older adults with late-life depression. Advances in our understanding of the neurobiology can help inform diagnosis and prognosis.


Randall Wong, MD

Latest:

E-mail, Intimacy, and Concierge Medicine

E-mail is not for every physician. Legal concerns and HIPAA compliance are perceived barriers to using e-mail. They are excuses. There are, however, practical reasons that prevent most docs from considering e-mail.


Randi Hagerman, MD

Latest:

Autism Spectrum Disorders, Down Syndrome, and 22q Deletion Syndrome

With aging, a multitude of medical conditions can occur and/or existing conditions can be exacerbated, contributing causally to or amplifying neuropsychiatric comorbidities.

© 2024 MJH Life Sciences

All rights reserved.